You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 12, December 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  History of Neurology
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Brief History of the Use of Interferons as Treatment of Multiple Sclerosis

Lawrence Jacobs, MD; Kenneth P. Johnson, MD

Arch Neurol. 1994;51(12):1245-1252.


Abstract

Interferons (IFNs) are a family of glycoproteins that are naturally secreted by certain cells in response to viral infection. The naturally occurring IFNs confer protection on other cells, preventing them from becoming infected, a phenomenon referred to as "virus interference" by Isaacs and Lindenmann1 in the first description of these proteins. In addition to their antiviral properties, the IFNs also have complex immunomodulatory, antiproliferative, and hormonelike activities, which are not completely understood.24



Author Affiliations

From the Departments of Neurology, University at Buffalo (NY) (Dr Jacobs) and University of Maryland, Baltimore (Dr Johnson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interferon-{{alpha}} Inhibits Proliferation in Human T Lymphocytes by Abrogation of Interleukin 2-induced Changes in Cell Cycle-regulatory Proteins
Erickson et al.
Cell Growth Differ. 1999;10:575-582.
ABSTRACT | FULL TEXT  

Interferons in the Treatment of Multiple Sclerosis: Do They Prevent the Progression of the Disease?
Rice and Ebers
Arch Neurol 1998;55:1578-1580.
FULL TEXT  

Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-{beta}1b-treated multiple sclerosis patients
Ferrarini et al.
Mult Scler 1998;4:174-177.
ABSTRACT  

Interferon gamma producing blood lymphocytes are decreased by interferon beta therapy in patients with multiple sclerosis
Petereit et al.
Mult Scler 1997;3:180-183.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.